Skip to main content

What do you think of our new website?

Ministry of Health
  1. Home
  2. Managing expenses
  3. Schemes and subsidies
  4. MediShield Life
  5. FAQs on cancer treatment financing

FAQs on cancer treatment financing

Find answers regarding the changes to cancer treatment financing and on the Cancer Drug List.

Last updated 6 December 2024

Cancer Treatment Financing FAQs

Why are there changes to cancer treatment financing?
How will the new Cancer Drug Treatment benefit impact my claims from 1 September 2022?
Does the Cancer Drug List also apply to inpatient cancer drug treatments?
Is there support for patients already undergoing cancer drug treatment that is not on the Cancer Drug List when the changes kicked in?
What are the criteria for inclusion in the Cancer Drug List?
Who assesses the cost-effectiveness of cancer drug treatments?
How can I apply for treatments to be added to the CDL?
What happens if cancer drugs are subsequently removed from the CDL?
Can a patient claim for cancer drug services from the Cancer Drug Services limit if he is receiving a treatment that is not on the CDL?
I am prescribed a drug that is not on the Cancer Drug List. Can I claim for the drug under the Cancer Drug Services Limit?
How are claim limits sized when more than one cancer drug is used in the treatment?
Why is the claim limit for a particular combination treatment not the sum of all the claim limits for individual drugs in that combination?
What happens if I have to change treatment in the middle of the month? Does it mean that the new treatment is not claimable?
My cancer drug treatment is on a 3-weekly cycle. Is the cancer drug limit sufficient for months when I need to undergo 2 rounds of treatment?
Can I claim for a particular combination treatment if not all drugs in the combination are used, or if I use a different drug from the combination listed?